Category: Pharmaceutical Policy
How Brand Manufacturers Produce Their Own Generic Versions
By Joe Barnett On 7 May, 2026 Comments (0)
Discover how brand manufacturers produce authorized generics to protect profits after patent expiration. Learn about the manufacturing process, pricing strategies, and consumer impact of this pharmaceutical tactic.
View MoreGlobal Biosimilar Markets: Europe vs United States Comparison
By Joe Barnett On 15 Apr, 2026 Comments (10)
A detailed comparison of biosimilar markets in Europe and the US, exploring regulatory shifts, patent cliffs, and the race for healthcare cost reduction.
View MoreGeneric Drug Shortages: The Paradox of Competition and Supply
By Joe Barnett On 14 Apr, 2026 Comments (0)
Explore the paradox of generic drug shortages: why more competition can actually lead to fewer manufacturers and unstable medical supplies.
View MoreRegulatory Exclusivity Explained: Non-Patent Market Protections in Pharma
By Joe Barnett On 26 Mar, 2026 Comments (8)
Regulatory exclusivity acts as a market protection tool separate from patents, blocking generic competition for specific periods. Learn how FDA rules shape drug pricing and availability.
View More
